
PR Newswire
ZEGFROVY is the only approved targeted oral treatment for NSCLC with EGFR exon20ins Approval...
SHANGHAI, July 3, 2025 /PRNewswire/ -- On July 2nd, the much-anticipated exhibition "Journey of Lig...
HSINCHU, July 3, 2025 /PRNewswire/ -- Gwo Xi Stem Cell Applied Technology Co., Ltd. (TPEx: 6704) is...
KUALA LUMPUR, Malaysia, July 3, 2025 /PRNewswire/ -- Eye Level Malaysia, a leading name in suppleme...
Beauty and Peril of Vanishing Glaciers Taking Centre Stage in Onewater's Global Photography Exhibit...
MADRID, July 3, 2025 /PRNewswire/ -- International company MelBet has announced a partnership with ...
VANCOUVER, BC, July 3, 2025 /PRNewswire/ -- MiniTool Software Limited has released a new vers...
HO CHI MINH CITY, Vietnam, July 3, 2025 /PRNewswire/ -- Vietnam takes a bold step forward in its cl...
Packed with powerful AI, innovative software, and cutting-edge hardware, both devices deliver unmatc...
SINGAPORE, July 3, 2025 /PRNewswire/ -- CDNetworks, the APAC-leading network to deliver edge...
TAIPEI, July 3, 2025 /PRNewswire/ -- As generative AI and edge computing technologies continue to e...
NINGBO, China, July 3, 2025 /PRNewswire/ -- A milestone in global heterojunction (HJT) photovoltaic...


ภาษาไทย
English